Drug Profile
CCX 025
Alternative Names: CCR9 2G; CCX025Latest Information Update: 01 Dec 2022
Price :
$50
*
At a glance
- Originator ChemoCentryx
- Class Anti-inflammatories; Antiulcers; Small molecules
- Mechanism of Action CCR9 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastrointestinal disorders